A Phase III Randomized, Double-blind, Parallel-group Study to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg Plus Acarbose 50 mg Tablets) Versus Acarbose Alone in Subjects With Type 2 Diabetes Mellitus
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2010-11-22
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 220
- Registration Number
- NCT01245166
- Locations
- 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan
The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria
Phase 4
- Conditions
- First Posted Date
- 2006-06-30
- Last Posted Date
- 2006-06-30
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 60
- Registration Number
- NCT00346606
- Locations
- 🇨🇳
Department of Dermatology National Taiwan University Hospital, Taipei, Taiwan
Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine
Phase 3
Completed
- Conditions
- First Posted Date
- 2006-06-06
- Last Posted Date
- 2007-09-10
- Lead Sponsor
- Lotus Pharmaceutical
- Target Recruit Count
- 74
- Registration Number
- NCT00334178
- Locations
- 🇨🇳
Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
🇨🇳Taipei Medical University Hospital, Taipei, Taiwan
🇨🇳Changhua Christian Hospital, Changhua, Taiwan
© Copyright 2024. All Rights Reserved by MedPath